Top Markets
#1 Cortex Cortex +174.45%
#2 GEKKO GEKKO +52.86%
#3 ADO Protocol ADO Protocol +18.49%
#4 o1.exchange o1.exchange +12.65%
#5 Audiera Audiera +11.26%
#6 Status Status +10.78%
#7 Official Trump Official Trump +10.62%
#8 Seeker Seeker +9.07%
#9 aelf aelf +8.94%
#10 Merlin's Seal BTC Merlin's Seal BTC +8.41%
Coin of the day
Cortex Cortex
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

688076
Clasificación en acciones #8443
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company,... Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
Precio por acción
$3.99
Última sincronización: 2026-08-28
Capitalización bursátil
$1.26B
Cambio (1 día)
-0.04%
Cambio (1 año)
-33.48%
País
CN
Comercio Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)

Categoría

Healthcare
Ganancias de Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Sinopep-Allsino Bio Pharmaceutical Co.,Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH